Diversity, equity and inclusion (DEI) have become important elements in the landscape of clinical research. It is important for the principles of DEI to be understood for their goals, intended outcomes and applications; otherwise, they may be regarded as mere buzzwords or just another box to tick on organizational mandates.
DEI are critical components of building a thriving, fair, all-encompassing, respectful and innovative society. By understanding and actively promoting DEI, individuals and organizations can help create environments where everyone has the opportunity to succeed regardless of their background or identity by overcoming and dismantling systemic discriminatory barriers.
Implementing DEI principles is not without challenges. It requires ongoing commitment, education and sometimes difficult conversations. There can be resistance to change, and it may take time to dismantle long-standing biases and systemic barriers.
Building DEI within life science organizations, particularly in the area of clinical research, is not just a social imperative but also a scientific one, ensuring that drugs developed are both safe and effective for the populations they are intended to serve.
To shed greater light on incorporating DEI practices and plans in clinical research, Xtalks spoke with Stacy Weil, DHI, Senior Vice President, Business Operations and Patient Centricity.
Webinar 
Perspectives Blog 